Human postmortem brain studies demonstrated lower aromatase expression in the hypothalamus of Alzheimer’s disease13 and depression patients14, and in the frontal cortex of autism spectrum disorder (ASD) patients15,16, as compared with the same brain regions of control subjects. This evidence concerns the gene CYP19A1 and autism spectrum disorder.